Inpatient Management of Pain Episodes in Children with Sickle Cell Disease: A Review

Author:

Barnawi Zhour12,Thomas Ronay3,Peddinti Radhika1,Abou Baker Nabil3ORCID

Affiliation:

1. Department of Pediatrics, Section of Hematology-Oncology and Bone Marrow Transplant, University of Chicago Medicine, Chicago, IL 60637, USA

2. Department of Pediatrics, King Abdulaziz University, Jeddah 21589, Saudi Arabia

3. Department of Medicine and Department of Pediatrics, University of Chicago, Chicago, IL 60637, USA

Abstract

Sickle cell disease (SCD) is the most common hemoglobinopathy in the world. Sickle cell vaso-occlusive episodes (VOEs) are very painful acute events and the most common complication as well as reason for hospitalization. SCD pain is best evaluated holistically with a pain functional assessment to aid in focusing pain management on reducing pain in addition to improving function. Patients with SCD have long endured structural racism and negative implicit bias surrounding the management of pain. Thus, it is important to approach the management of inpatient pain systematically with the use of multi-modal medications and nonpharmacologic treatments. Furthermore, equitable pain management care can be better achieved with standardized pain plans for an entire system and individualized pain plans for patients who fall outside the scope of the standardized pain plans. In this article, we discuss the best practices to manage SCD VOEs during an inpatient hospitalization.

Publisher

MDPI AG

Reference61 articles.

1. (2024, April 28). What Is Sickle Cell Disease (SCD)?, Available online: https://www.cdc.gov/ncbddd/sicklecell/features/what-is-scd.html.

2. Characterisation of medical conditions of children with sickle cell disease in the USA: Findings from the 2007–2018 National Health Interview Survey (NHIS);Gyamfi;BMJ Open,2023

3. Differences in the clinical and genotypic presentation of sickle cell disease around the world;Saraf;Paediatr. Respir. Rev.,2014

4. A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin;Ingram;Nature,1956

5. Pathophysiology of Sickle Cell Disease;Sundd;Annu. Rev. Pathol.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3